Brief: Consun Pharmaceutical Group Says HY Revenue Rmb941 Mln, Up 8.3%
Aug 21 (Reuters) - Consun Pharmaceutical Group Ltd
1681.HK :
* HY REVENUE RMB941,036,000, UP 8.3%
* HY PROFIT ATTRIBUTABLE RMB 249.5 MILLION ,UP 13.9%
* BOARD HAS DECLARED AN INTERIM DIVIDEND OF HKD0.1 PER SHARE
Source text for Eikon: ID:nHKSc65K31
Further company coverage: 1681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Consun Pharmaceutical
See all newsChina's Consun Pharmaceutical H1 revenue rises on sales network expansion
Brief: Consun Pharmaceutical Says Unit To Invest RMB191.4 Mln In Shanghai Huamao Pharmaceutical
Brief: Consun Pharmaceutical Group Announces Share Repurchase Program Up To HKD200 Million
Brief: Consun Pharmaceutical Logs FY Revenue RMB 3,420 Mln
Brief: Consun Pharmaceutical Says Executive Director Zhu Quan Redesignated As Non-Executive Director